TTrialPathMatch Me to Trials
← Back to trials
RecruitingType 2 DiabetesChronic Kidney Diseases

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Eligible age

18–80 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The aim of this protocol is to assess the presence and severity of primary aldosteronism pathophysiology in patients with type 2 diabetes who have, or are at-risk for developing, chronic kidney disease.

Sponsor: Brigham and Women's Hospital

You may qualify if…

  • 1. Age 18-80 years
  • 2. Known diagnosis of type 2 diabetes; or unknown/unclear diagnosis of type 2 diabetes but hemoglobin A1c 5.7-6.4% on screening while on treatment with metformin or SGLT2 inhibitor or GLP1RA class of medications; or unknown/unclear diagnosis of type 2 diabetes but hemoglobin A1c 6.5-8.9% on screening.
  • 3. One of the two following inclusion criteria i. At-risk for developing CKD: eGFR 60-89 mL/min/1.73m2 plus at least one of the following:
  • Moderate albuminuria (30-300 mg/g)
  • Diagnosis of hypertension or active treatment with anti-hypertensive medications
  • BMI ≥ 30 kg/m2 ii. At-risk for CKD progression: eGFR 45-60 mL/min/1.73m2

You may not qualify if…

  • Type 1 or Type 3 diabetes
  • Hemoglobin A1c ≥ 9%
  • Inability to safely participate in fasting study visits (determination at the discretion of PI and MD study staff based on cumulative assessment of safety factors)
  • Average blood pressure at screening visit of \>150 mmHg systolic or \>100 mmHg diastolic
  • Screening average systolic blood pressure less than 105 mmHg without the use of an ACE inhibitor or angiotensin receptor blocker
  • Inability to safely withdraw ACE inhibitor or angiotensin receptor blocker medication in lieu of alternative medication for a few weeks (determination at the discretion of PI and MD study staff based on cumulative assessment of factors)
  • Known history of stroke, symptomatic coronary artery disease, myocardial infarction, heart failure, cerebral or aortic aneurysm.
  • Known cardiac murmur suggestive of aortic stenosis or mitral regurgitation, or detected newly on screening physical examination

Where it's recruiting

Source: ClinicalTrials.gov · NCT06190158 · last updated 2025-04-09

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disea · TrialPath